| ￥3500 | |
| Z04839-100 | |
|
|
|
|
|
|
|
|
|
| Species | Cynomolgus | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | E.coli | ||||
| Theoretical Molecular Weight | 15.13 kDa | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 15.13 kDa same as Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of IL-3, His, Cynomolgus is greater than 95% as determined by SEC-HPLC. »
IL-3, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Cynomolgus IL-3 R alpha, His Tag immobilized on CM5 Chip can bind IL-3, His, Cynomolgus, His Tag with an affinity constant of 1.30 nM as determined in SPR assay (Biacore T200). »
| Target Background | Interleukin 3 is a pleiotropic factor produced primarily by activated T cells that can stimulate the proliferation and differentiation of pluripotent hematopoietic stem cells as well as various lineage committed progenitors. This CSF induces granulocytes, macrophages, mast cells, stem cells, erythroid cells, eosinophils and megakaryocytes. |
| Synonyms | IL3; IL-3; IL-3MGC79398; interleukin-3; MULTI-CSF; MCGF |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
